Clinical Trial

Alopecia Clinical Trial 20223030

[LCID Study Number: 20223030]

A Pilot Clinical ‘Proof of Concept’ Study of Activated Platelet-rich Plasma in Subjects with Androgenetic Alopecia (AGA)

The purpose of this study is to assess the effects and safety of platelet-rich plasma (PRP) activated with pulsed electrical fields (PEFA-PRP) compared with unactivated PRP when used to treat androgenetic alopecia (AGA).

Disease/Condition: Alopecia

Department: Physical Medicine & Rehabilitation

Location(s): Winchester Hospital

Primary Contact Email:

Primary Contact Phone: 781-729-8833

Clinical Trial Details

View NCT ID 05348343 on

Protocol #: 20223030

Principal Investigator(s): Maryanne M Senna

Study Coordinator(s): Jahnvi Patel

Trial Phase: Sponsor Initiated Study Phase 1